The story of copyright's flagship drug presents a complex case for investors in the medicinal sector. While initially a phenomenal success, generating huge profits, the patent end and the subsequent arrival of generic https://escort862070.tblogz.com/the-little-copyright-and-the-pharmaceutical-industry-a-risky-investment-54965151